J Gerry Coghlan

Summary

Affiliation: Royal Free Hospital
Country: UK

Publications

  1. ncbi Assessment of endpoints in pulmonary arterial hypertension associated with connective tissue disease
    J Gerry Coghlan
    Royal Free Hospital, London, UK
    Curr Opin Pulm Med 16:S27-34. 2010
  2. ncbi Cardiac assessment of patients for haematopoietic stem cell transplantation
    J G Coghlan
    Department of Cardiology, Royal Free Hospital, Pond Street, Hampstead, London NW3 2QG, UK
    Best Pract Res Clin Haematol 20:247-63. 2007
  3. ncbi Connective tissue associated pulmonary arterial hypertension
    J G Coghlan
    Department of Cardiology, Royal Free Hospital, London, UK
    Lupus 15:138-42. 2006
  4. ncbi Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach
    D Mukerjee
    Department of Rheumatology, Royal Free Hospital, Pond Street, London NW3 2QG, UK
    Ann Rheum Dis 62:1088-93. 2003
  5. ncbi Pulmonary artery hypertension as the presenting feature of systemic sclerosis sine scleroderma
    J D Pauling
    Rheumatology (Oxford) 47:1431-2. 2008
  6. ncbi Can CCL2 serum levels be used in risk stratification or to monitor treatment response in systemic sclerosis?
    M T Carulli
    Centre for Rheumatology, Royal Free and University College Medical School, Rowland Hill Street, Hampstead, London, NW3 2PF, UK
    Ann Rheum Dis 67:105-9. 2008
  7. ncbi Systemic sclerosis associated pulmonary hypertension: improved survival in the current era
    M H Williams
    Department of Cardiology, Royal Free Hospital, London, UK
    Heart 92:926-32. 2006
  8. ncbi Real-time myocardial contrast dobutamine stress echocardiography in coronary stenosis
    Elved B Roberts
    Cardiology Department, Royal Free Hospital, London, United Kingdom
    Int J Cardiol 113:19-24. 2006
  9. ncbi The myth of pulmonary Raynaud's phenomenon: the contribution of pulmonary arterial vasospasm in patients with systemic sclerosis related pulmonary arterial hypertension
    D Mukerjee
    Centre for Rheumatology, Royal Free Hospital, London, UK
    Ann Rheum Dis 63:1627-31. 2004
  10. ncbi A new era in the management of pulmonary arterial hypertension related to scleroderma: endothelin receptor antagonism
    E Hachulla
    Service de Medecine Interne, Hopital Claude Huriez, Centre Hospitalier et Universitaire, 59037 Lille, France
    Ann Rheum Dis 63:1009-14. 2004

Collaborators

Detail Information

Publications13

  1. ncbi Assessment of endpoints in pulmonary arterial hypertension associated with connective tissue disease
    J Gerry Coghlan
    Royal Free Hospital, London, UK
    Curr Opin Pulm Med 16:S27-34. 2010
    ....
  2. ncbi Cardiac assessment of patients for haematopoietic stem cell transplantation
    J G Coghlan
    Department of Cardiology, Royal Free Hospital, Pond Street, Hampstead, London NW3 2QG, UK
    Best Pract Res Clin Haematol 20:247-63. 2007
    ....
  3. ncbi Connective tissue associated pulmonary arterial hypertension
    J G Coghlan
    Department of Cardiology, Royal Free Hospital, London, UK
    Lupus 15:138-42. 2006
    ..Early diagnosis is most readily achieved in patients with connective tissue disease associated pulmonary hypertension. This represents an opportunity for those with an interest in academic rheumatology...
  4. ncbi Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach
    D Mukerjee
    Department of Rheumatology, Royal Free Hospital, Pond Street, London NW3 2QG, UK
    Ann Rheum Dis 62:1088-93. 2003
    ..A high mRAP was the strongest haemodynamic predictor of mortality. To improve prognosis, future treatments need to be implemented at an earlier disease stage to prevent right ventricular decompensation...
  5. ncbi Pulmonary artery hypertension as the presenting feature of systemic sclerosis sine scleroderma
    J D Pauling
    Rheumatology (Oxford) 47:1431-2. 2008
  6. ncbi Can CCL2 serum levels be used in risk stratification or to monitor treatment response in systemic sclerosis?
    M T Carulli
    Centre for Rheumatology, Royal Free and University College Medical School, Rowland Hill Street, Hampstead, London, NW3 2PF, UK
    Ann Rheum Dis 67:105-9. 2008
    ..To explore the potential value of serum CCL2 measurement in disease assessment, we have compared CCL2 levels with clinical phenotype and investigated effect of therapy on circulating CCL2...
  7. ncbi Systemic sclerosis associated pulmonary hypertension: improved survival in the current era
    M H Williams
    Department of Cardiology, Royal Free Hospital, London, UK
    Heart 92:926-32. 2006
    ..In contrast to patients treated historically with basic drugs and prostanoids, patients treated in the current treatment era had improved survival associated with a lack of deterioration in cardiac haemodynamic function...
  8. ncbi Real-time myocardial contrast dobutamine stress echocardiography in coronary stenosis
    Elved B Roberts
    Cardiology Department, Royal Free Hospital, London, United Kingdom
    Int J Cardiol 113:19-24. 2006
    ..Simultaneous wall motion and myocardial perfusion analysis could offer advantages over either method alone. Diagnostic utility of combining these parameters during dobutamine stress echocardiography is evaluated in this study...
  9. ncbi The myth of pulmonary Raynaud's phenomenon: the contribution of pulmonary arterial vasospasm in patients with systemic sclerosis related pulmonary arterial hypertension
    D Mukerjee
    Centre for Rheumatology, Royal Free Hospital, London, UK
    Ann Rheum Dis 63:1627-31. 2004
    ..To investigate the contribution of cold induced pulmonary vasospasm by peripheral and central cold stimulus in exacerbating pulmonary arterial hypertension (PAH) in patients with systemic sclerosis undergoing cardiac catheterisation...
  10. ncbi A new era in the management of pulmonary arterial hypertension related to scleroderma: endothelin receptor antagonism
    E Hachulla
    Service de Medecine Interne, Hopital Claude Huriez, Centre Hospitalier et Universitaire, 59037 Lille, France
    Ann Rheum Dis 63:1009-14. 2004
    ..Heightened vigilance towards early detection of PAH in scleroderma and a multidisciplinary approach to diagnosis and treatment may improve clinical outcomes for these patients...
  11. ncbi Echocardiography and pulmonary function as screening tests for pulmonary arterial hypertension in systemic sclerosis
    D Mukerjee
    Department of Rheumatology, Royal Free Hospital, Pond Street, London NW32QG, UK
    Rheumatology (Oxford) 43:461-6. 2004
    ..These tests cannot be relied upon to exclude pulmonary hypertension where pre-test probability is high...
  12. ncbi Significance of plasma N-terminal pro-brain natriuretic peptide in patients with systemic sclerosis-related pulmonary arterial hypertension
    D Mukerjee
    Royal Free Campus, Centre for Rheumatology, Pond Street, Rowland Hill Street, London NW32QG, UK
    Respir Med 97:1230-6. 2003
    ..A single centre pilot study to investigate the role of the plasma N-terminal pro-brain natriuretic peptide (N-T proBNP) assay to risk stratify patients with suspected pulmonary arterial hypertension (PAH) from a background SSc population...
  13. ncbi Pathophysiological insights from a case of reversible pulmonary arterial hypertension
    D Mukerjee
    Department of Rheumatology, Royal Free Hospital, Pond Street, London NW3 2QG, UK
    J R Soc Med 96:403-4. 2003